Goldman Sachs Group Inc Biomerica Inc Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding BMRA
# of Institutions
28Shares Held
1.79MCall Options Held
53.7KPut Options Held
0-
Granahan Investment Management, LLC Waltham, MA527KShares$147,6890.01% of portfolio
-
Russell Investments Group, Ltd.225KShares$63,1210.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA169KShares$47,3220.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$46,9560.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$41,7420.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $3.76M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...